Johnson & Johnson has agreed to acquire Shockwave Medical Inc. in an all-cash deal with an enterprise value of about $13 billion, in a move that will boost its share of the market for medical ...
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated.
The average one-year price target for Shockwave Medical (NasdaqGS:SWAV) has been revised to 322.46 / share. This is an increase of 17.23% from the prior estimate of 275.06 dated March 28 ...
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated.